Webinar: InMed Pharmaceuticals

Webinar: InMed Pharmaceuticals

InMed Pharmaceuticals — 14 videos in collection

More on this equity

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs.

In this webinar, CEO Eric Adams and CFO Bruce Colwill present an overview of the company’s recent operating and financial activities. A brief Q&A session follows the presentation.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free